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Association of Low Socioeconomic Status With Hidradenitis Suppurativa in the United States
Socioeconomic status (SES) is a critical determinant of health outcome; however, no previous studies, to our knowledge, have evaluated SES among patients with hidradenitis suppurativa (HS) in the United States. Therefore we sought to determine whether HS was associated with low SES in a US population-based sample.
Methods | This cross-sectional cohort analysis used multiple health systems data that constitute the data analytics and research platform (Explorys) developed by the IBM Corporation Watson Health team. Clinical information from electronic medical records, laboratories, practice management systems, and claims systems was matched using the single set of Unified Medical Language System ontologies to create longitudinal records for unique patients. The data were standard- Elements used in the intervention are shown with instructions printed in English although they were printed in German for the study. The screen shows the selfie view, which appears after "start" is tapped on the start screen.
ized and curated according to common controlled vocabularies and classifications systems, including the International Classification of Diseases, SNOMED-CT (Systemized Nomenclature of Medicine-Clinical Terms), LOINC (Logical Observation Identifiers Names and Codes), and RxNorm. We compared the prevalence of low SES among patients with and without HS. The SNOMED-CT term hidradenitis was used to identify patients with HS.
1 The primary outcome of interest was Medicaid insurance status, which was used as a proxy for low SES. 2 The study population included adults aged 18 to 64 years with an active status in the database within the past 3 years and complete information on age, sex, race/ethnicity, and body mass index. Prevalence was compared using an adjusted odds ratio from a logistic regression model controlling for age, sex, race/ethnicity, obesity, and smoking status. This study was approved by the human subjects committee at the Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York, which waived the need for informed consent for these deidentified data.
Results | We identified 27 615 patients with HS whose characteristics are described in the Table ( 24.0% men and 76.0% women). Low SES occurred among 6195 patients with HS (22.4%) compared with 898 130 of 6 633 750 patients without HS (13.5%; P < .001). Hidradenitis suppurativa was associated with low SES in the crude analysis (odds ratio, 1.85; 95% CI, 1.80-1.90). In multivariable analysis, the association was significant with only a modest effect size (odds ratio, 1.13; 95% CI, 1.09-1.16).
Discussion | Patients in the United States with HS are more likely to have low SES compared with patients without HS. However, the strength of association in our analysis is highly attenuated after accounting for relevant covariates, including age, sex, obesity, tobacco smoking, and race/ethnicity.
In a Dutch cohort analysis 3 that included approximately 1018 patients with HS, lower SES, as determined by zip code analysis of mean household income and real estate values, was significantly more frequent among the patients with HS compared with an age-and sex-matched reference group (46.4% vs 34.3%; P < .001). However, the primary analysis in this study did not account for important covariates such as obesity, smoking status, and race, which in the United States may be associated with HS as well as the outcome of low SES.
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We were unable to evaluate educational attainment or employment status within the framework of this database. We also could not determine directionality between HS and SES in this analysis. However, we speculate that the modest association of HS with low SES shown in this analysis is a consequence of the quality-of-life effects (ie, symptoms including pain and malodorous discharge) of HS, and that low SES may not be a driver for the development of HS. Nonetheless, we suggest an attentive awareness to the potential for disparate outcomes among patients with HS who have low SES. However, to our knowledge, there have been no studies evaluating the association between LPP, hyperlipidemia, and metabolic syndrome.
Methods | Patients with LPP seen at the Cleveland Clinic during the period from January 1, 2003, to June 12, 2011, were identified using the Cleveland Clinic alopecia registry (n = 187). For inclusion into the LPP registry, patients must have received a scalp biopsy with results showing histopathologic characteristics of LPP. The characteristics of these patients were compared with the characteristics of patients with seborrheic dermatitis (n = 56). The electronic health record was reviewed for demographic (age, sex, and body mass index [calculated as weight in kilograms divided by height in meters squared]), clinical (type 1 diabetes, hypertension, and dyslipidemia), and laboratory characteristics. Hypercholesterolemia was defined as a serum low-density lipoprotein level of higher than 130 mg/dL (to convert to millimoles per liter, multiply by 0.0259) or a serum total cholesterol level of higher than 200 mg/dL (to convert to millimoles per liter, multiply by 0.0259), or was based on the use of lipid-lowering medications. Hypertriglyceridemia was defined as a serum triglyceride level of higher than 150 mg/dL (to convert to millimoles per liter, multiply by 0.0113). Statistical analysis was performed from July 8 to 29, 2011. Continuous variables were analyzed with the Mann-Whitney test. Differences between categorical variables were assessed using the χ 2 and Fisher exact tests when appropriate. Statistical significance was set as P < .05. This study was approved by the Cleveland Clinic Institutional Review Board. Patient consent was waived by the Cleveland Clinic Institutional Review Board, as the data were collected retrospectively.
Results | The study included 243 participants: 187 patients with LPP and 56 controls (Table) Discussion | Despite the connection between hyperlipidemia and lichen planus, no differences were found in this group of patients with LPP. Confounding factors such as age, body mass index, and hypertension were homogeneous in both groups. This study has several limitations. The different ranges of LPP duration in this study may have influenced the lipid profiles and could potentially bias the estimates toward a smaller difference between patients with LPP and healthy controls. In addition, this study was conducted at a tertiary care center renowned for its cardiology department, and the composition of patients may be different compared with the general population. Our study cannot definitively exclude the possibility of a correlation between dyslipidemia and LPP. Prospective studies with larger numbers of patients are required to further investigate the potential correlation between dyslipidemia and LPP.
